A systematic investigation of the contribution of genetic variation within the MHC region to HPV seropositivity

Dan Chen, Valérie Gaborieau, Yao Zhao, Amélie Chabrier, Huibo Wang, Tim Waterboer, David Zaridze, Jolanta Lissowska, Peter Rudnai, Eleonora Fabianova, Vladimir Bencko, Vladimir Janout, Lenka Foretova, Ioan Nicolae Mates, Neonila Szeszenia-Dabrowska, Paolo Boffetta, Michael Pawlita, Mark Lathrop, Ulf Gyllensten, Paul BrennanJames D. McKay

Research output: Article

9 Citations (Scopus)

Abstract

High-risk mucosal types of human papillomavirus (HPV) cause anogenital and oropharyngeal cancers, whereas cutaneous types (e.g. HPV8 and 77) are suspected to be involved in non-melanoma skin cancer. The antibody response to HPVs is a key determinant of protective immunity, but not all infected individuals seroconvert. Genetic variability of the host may have large impact on seroconversion. A previous genome-wide association study (GWAS) has identified a susceptibility locus (rs41270488) for HPV8 seropositivity within the major histocompatibility complex (MHC) region. To further study this locus, we imputed alleles at classical leukocyte antigen (HLA) loci using HLA*IMP:02 with a reference panel from the HapMap Project and the 1958 Birth Cohort, and conducted an integrated analysis among 4811 central European subjects to assess the contribution of classical HLA alleles and gene copy number variation (CNV) at the hypervariable DRB locus within the MHC region to HPV seropositivity at both the individual HPV type level and the phylogenetic species level. Our study provides evidence that the association noted between rs41270488 and HPV8 seropositivity is driven by two independent variants, namely DQB1*0301 [odds ratio (OR) = 1.51, 95% confidence interval (CI) = 1.36-1.68, P = 1.0 × 10-14] and DRB1*1101 (OR = 1.89, 95%CI = 1.57-2.28, P = 1.5 × 10-11) within the HLA class II region. Additionally, we identified two correlated alleles DRB1*0701 (OR = 1.67, 95%CI = 1.41-1.98, P = 2.6 × 10-9) and DQA1*0201 (OR = 1.67, 95%CI = 1.38-1.93, P = 1.7 × 10-8), to be associated with HPV77 seropositivity. Comparable results were observed through imputation using SNP2HLA with another reference panel from the Type 1 diabetes Genetics Consortium. This study provides support for an important role of HLA class II alleles in antibody response to HPV infection.

Original languageEnglish
Pages (from-to)2681-2688
Number of pages8
JournalHuman molecular genetics
Volume24
Issue number9
DOIs
Publication statusPublished - 2015

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'A systematic investigation of the contribution of genetic variation within the MHC region to HPV seropositivity'. Together they form a unique fingerprint.

  • Cite this

    Chen, D., Gaborieau, V., Zhao, Y., Chabrier, A., Wang, H., Waterboer, T., Zaridze, D., Lissowska, J., Rudnai, P., Fabianova, E., Bencko, V., Janout, V., Foretova, L., Mates, I. N., Szeszenia-Dabrowska, N., Boffetta, P., Pawlita, M., Lathrop, M., Gyllensten, U., ... McKay, J. D. (2015). A systematic investigation of the contribution of genetic variation within the MHC region to HPV seropositivity. Human molecular genetics, 24(9), 2681-2688. https://doi.org/10.1093/hmg/ddv015